Aller au contenu principal
Profil bibliographique

Noel Chan

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

153Publications signalées
3188Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

Atrial Fibrillation Management and OutcomesVenous Thromboembolism Diagnosis and ManagementAntiplatelet Therapy and Cardiovascular DiseasesCerebral Venous Sinus ThrombosisOphthalmology and Eye Disorders

Les publications récentes

Accès ouvert 2026 article OpenAlex

An AI-Based OCT System to Detect Diabetic Macular Edema

Shuyi Zhang, Anran Ran, Jie Zhou, Anni Ling et autres

Importance: Screening for diabetic retinopathy using fundus photographs is the global standard of care but results in high false-positive referrals to evaluate diabetic macular edema (DME), placing a substantial burden on specialist eye clinics. Integrating an AI-based optical coherence tomography (AI-OCT) system …

hk, cn, gb, sg (code pays fourni par la source)

0 citations JAMA
Accès ouvert 2025 article OpenAlex

Current Evidence and Future Directions for Colchicine in the Prevention of Atherosclerotic Cardiovascular Disease

Aimée Marjolijn Healey van Zelm, Aernoud T.L. Fiolet, Robert J. Hinchliffe, Shirley Jansen et autres

Chronic inflammation plays a key role in the development and progression of atherosclerotic cardiovascular disease (ASCVD) and its complications. Despite the use of blood pressure-, lipid-, and glucose-lowering therapies as well as antithrombotic agents, the lifetime residual cardiovascular (CV) risk in patients …

nl, gb, au, ca (code pays fourni par la source)

1 citation Thrombosis and Haemostasis
Accès ouvert 2025 review OpenAlex

Colchicine for secondary prevention of vascular events: a meta-analysis of trials

Marc-André d'Entremont, Michiel H.F. Poorthuis, Aernoud T.L. Fiolet, Pierre Amarenco et autres

BACKGROUND AND AIMS: Randomized trials of colchicine in secondary prevention of atherosclerotic cardiovascular disease have shown mixed results. METHODS: A systematic review and study-level meta-analysis of randomized controlled trials was performed comparing colchicine vs no colchicine in a secondary-prevention atherosclerotic cardiovascular disease …

0 citations Utrecht University Repository (Utrecht University)
Accès ouvert 2025 article OpenAlex

Exploring the ABO-VTE connection

Noel Chan, Jack Hirsh

age (NCT04801797).Notably, the study excludes patients with core binding factor and FLT3-mutated AML.The National Cancer Institute-sponsored MyeloMATCH portfolio of trials has 2 trials in patients 18 to 59 years of age, which are testing various induction strategies, including anthracycline-cytarabine and VEN-HMA, in …

ca (code pays fourni par la source)

1 citation Blood
Accès ouvert 2025 review OpenAlex

Colchicine for secondary prevention of vascular events: a meta-analysis of trials

Marc-André d’Entremont, Michiel H.F. Poorthuis, Aernoud T.L. Fiolet, Pierre Amarenco et autres

BACKGROUND AND AIMS: Randomized trials of colchicine in secondary prevention of atherosclerotic cardiovascular disease have shown mixed results. METHODS: A systematic review and study-level meta-analysis of randomized controlled trials was performed comparing colchicine vs no colchicine in a secondary-prevention atherosclerotic cardiovascular disease …

ca, nl, jp, be, us, au, mk, fr, es, cn, ie (code pays fourni par la source)

59 citations European Heart Journal

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.